CAPTRUST Financial Advisors’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-2,735
Closed -$478K 2948
2020
Q1
$478K Buy
2,735
+158
+6% +$29.8K 0.01% 602
2019
Q4
$495K Buy
2,577
+1,067
+71% +$192K 0.01% 689
2019
Q3
$254K Buy
1,510
+3
+0.2% +$489 0.01% 528
2019
Q2
$252K Buy
1,507
+454
+43% +$62.9K 0.01% 517
2019
Q1
$154K Sell
1,053
-27
-3% -$3.91K 0.01% 572
2018
Q4
$144K Buy
1,080
+60
+6% +$9.84K 0.01% 501
2018
Q3
$194K Buy
1,020
+157
+18% +$28.8K 0.01% 450
2018
Q2
$144K Sell
863
-625
-42% -$100K 0.01% 429
2018
Q1
$241K Buy
1,488
+421
+39% +$70.6K 0.01% 297
2017
Q4
$175K Buy
1,067
+1,033
+3,038% +$185K 0.01% 342
2017
Q3
$5K Buy
+34
New +$7.91K ﹤0.01% 491

Other funds holding AGN

CAPTRUST Financial Advisors's AGN Position: Q2 2020 in Review

CAPTRUST Financial Advisors sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 2,735 shares — an estimated $478K sold.

CAPTRUST Financial Advisors first reported a position in AGN in Q3 2017 and held it in 11 quarters. The position peaked at $495K in Q4 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • CAPTRUST Financial Advisors reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 2,735 Allergan plc shares in Q2 2020, an estimated $478K.
  • CAPTRUST Financial Advisors first reported a position in Allergan plc in Q3 2017 and held it in 11 quarters.
  • CAPTRUST Financial Advisors's Allergan plc position peaked at $495K in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on CAPTRUST Financial Advisors's 13F filing for Q2 2020, filed 14 Aug 2020.